triiodothyronine has been researched along with Fatty Liver, Nonalcoholic in 29 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The association between free triiodothyronine/free thyroxine (FT3/FT4) and non-alcoholic fatty liver disease (NAFLD) in euthyroid subjects is unclear." | 8.12 | Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population. ( Li, Z; Liu, HX; Ma, HJ; Meng, CQ; Nie, Q; Ren, YY; Yu, CH, 2022) |
| "FT3 is independently associated with NAFLD in hospitalized T2DM patients after rigorous adjustment for various metabolic parameters." | 5.62 | Free Triiodothyronine Is Independently Associated with Nonalcoholic Fatty Liver Disease in Hospitalized Type 2 Diabetes Mellitus Patients. ( Chen, Y; Hong, Y; Li, S; Lin, C; Shi, R; Xia, X; Xiu, L, 2021) |
| "NAFLD was diagnosed by ultrasound." | 5.51 | Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women. ( Bao, Y; Chen, P; Feng, L; Hou, X; Jia, W; Jiao, L; Wang, H; Wei, L; Zhong, L, 2019) |
| "NAFLD was defined by using the validated Fatty Liver Index (FLI); FLI≥60 was categorized as NAFLD." | 5.46 | Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study. ( Amini, M; Blokzijl, H; Dullaart, RP; Faber, KN; Schreuder, TC; van den Berg, EH; van Tienhoven-Wind, LJ, 2017) |
| "NAFLD was diagnosed by hepatic ultrasonography." | 5.42 | Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects. ( Guan, L; Guan, Q; Jiang, Q; Jiang, Z; Lin, H; Liu, G; Yu, C; Zhang, N; Zhang, X; Zhang, Y; Zheng, X, 2015) |
| " 3,5-diiodothyronine (T2) has been used with success in rat models of dyslipidemia and NAFLD, but the outcome of a clinical trial with a synthetic T2 analogue was disappointing." | 5.05 | Thyroid Hormone Analogues: An Update. ( Zucchi, R, 2020) |
| "Overweight/obesity mediated the associations of MAFLD with triiodothyronine (T3), free triiodothyronine (FT3), free thyroxine (FT4), and the mediator accounted for 46." | 4.31 | The association between thyroid hormones and MAFLD is mediated by obesity and metabolic disorders and varies among MAFLD subtypes. ( Cao, L; Chen, X; Fan, H; Li, L; Liu, Z; Suo, C; Zhang, T, 2023) |
| "The association between free triiodothyronine/free thyroxine (FT3/FT4) and non-alcoholic fatty liver disease (NAFLD) in euthyroid subjects is unclear." | 4.12 | Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population. ( Li, Z; Liu, HX; Ma, HJ; Meng, CQ; Nie, Q; Ren, YY; Yu, CH, 2022) |
| " We aimed to evaluate the power and effectiveness of the free triiodothyronine (FT3)-to-free thyroxine (FT4) ratio to predict non-alcoholic fatty liver disease (NAFLD)/liver fibrosis and NASH cirrhosis severity." | 4.02 | Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis? ( Ahbab, S; Ataoğlu, HE; Koçak, E; Oral, A; Şahin, T; Türker, BÇ; Türker, F, 2021) |
| "In euthyroid NAFLD patients, higher FT3/FT4, TFQI, TT4RI, and TSHI values were strongly associated with an increased incidence of advanced liver fibrosis." | 1.91 | Sensitivity to thyroid hormones is associated with advanced fibrosis in euthyroid patients with non-alcoholic fatty liver disease: A cross-sectional study. ( Chen, C; Cheng, X; Gao, M; Han, X; Li, J; Li, R; Zhou, L, 2023) |
| "The severity of liver fibrosis is an important predictor of death in patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM)." | 1.72 | The correlation between triiodothyronine and the severity of liver fibrosis. ( He, W; Huang, C; Huang, P; Huang, Y; Li, X; Lin, M; Shi, X; Su, W; Wang, L; Wang, S; Zhang, X; Zhao, Y, 2022) |
| "The incidence rate of NAFLD was 85." | 1.72 | High-Normal Thyroid Function Predicts Incident Nonalcoholic Fatty Liver Disease Among Middle-Aged and Older Euthyroid Subjects. ( Gu, Y; Jia, Q; Liu, L; Meng, G; Niu, K; Song, K; Sun, S; Wang, X; Wang, Y; Wu, H; Wu, X; Zhang, Q; Zhang, S; Zhang, T; Zhou, M, 2022) |
| "FT3 is independently associated with NAFLD in hospitalized T2DM patients after rigorous adjustment for various metabolic parameters." | 1.62 | Free Triiodothyronine Is Independently Associated with Nonalcoholic Fatty Liver Disease in Hospitalized Type 2 Diabetes Mellitus Patients. ( Chen, Y; Hong, Y; Li, S; Lin, C; Shi, R; Xia, X; Xiu, L, 2021) |
| "Thyroid function and type 2 diabetes mellitus (T2DM) are both associated with increased risks of adverse clinical outcomes in nonalcoholic fatty liver disease (NAFLD)." | 1.56 | Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients. ( Huang, B; Yang, S; Ye, S, 2020) |
| "Serum FT3 levels in subjects with NAFLD were significantly reduced, while TSH was increased compared to that in controls." | 1.56 | Serum Thyroid Hormones Levels are Significantly Associated with Nonalcoholic Fatty Liver Disease in Euthyroid Chinese Population. ( Dai, Y; Qin, J; Zhang, J; Zhang, X, 2020) |
| "NAFLD was diagnosed by ultrasound." | 1.51 | Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women. ( Bao, Y; Chen, P; Feng, L; Hou, X; Jia, W; Jiao, L; Wang, H; Wei, L; Zhong, L, 2019) |
| "In murine models of advanced nonalcoholic steatohepatitis (NASH), the administration of T3 reduced liver triglyceride, repressed liver inflammation, and attenuated injury." | 1.51 | Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis. ( Bechmann, L; Best, J; Canbay, A; Claridge, LC; Coombes, JD; Gerken, G; Manka, P; Moeller, L; Sydor, S; Syn, WK; Wedemeyer, H, 2019) |
| "NAFLD was diagnosed by ultrasound and fatty liver index (FLI)." | 1.48 | Thyroid Function and Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects. ( Liu, Y; Qi, X; Wang, W; Yu, X, 2018) |
| "NAFLD was defined by using the validated Fatty Liver Index (FLI); FLI≥60 was categorized as NAFLD." | 1.46 | Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study. ( Amini, M; Blokzijl, H; Dullaart, RP; Faber, KN; Schreuder, TC; van den Berg, EH; van Tienhoven-Wind, LJ, 2017) |
| "Hypothyroidism was considered at a thyroid stimulating hormone level ≥ 4." | 1.43 | FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism. ( Ahbab, S; Ataoğlu, HE; Çetin, F; Gökmen, FY; Mamaç, RY; Türker, BÇ; Türker, F; Yenigün, M, 2016) |
| "Subjects with NAFLD had significantly higher TSH levels and lower FT4 levels than those without NAFLD (p < 0." | 1.42 | Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects. ( Gu, H; Sui, J; Tao, Y; Wu, J, 2015) |
| "NAFLD was diagnosed by hepatic ultrasonography." | 1.42 | Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects. ( Guan, L; Guan, Q; Jiang, Q; Jiang, Z; Lin, H; Liu, G; Yu, C; Zhang, N; Zhang, X; Zhang, Y; Zheng, X, 2015) |
| "Non-alcoholic fatty liver disease (NAFLD) is one of the most common disorders of the liver worldwide." | 1.42 | Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years. ( Boehm, BO; Denzer, C; Graeter, T; Greinert, A; Haenle, MM; Holzner, D; Koenig, W; Kratzer, W; Ludwig, U; Mason, RA; Oeztuerk, S, 2015) |
| "NAFLD was diagnosed by conventional ultrasound examination." | 1.40 | Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease. ( Aydın, S; Cesur, Y; Gökçe, S; Özgen, IT; Torun, E, 2014) |
| "NAFLD and non-NAFLD groups had slightly higher fasting blood glucose values than the control group." | 1.40 | Thyroid function in obese children with non-alcoholic fatty liver disease. ( Bilgin, H; Pirgon, Ö, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (48.28) | 24.3611 |
| 2020's | 15 (51.72) | 2.80 |
| Authors | Studies |
|---|---|
| Shim, S | 1 |
| Krishnaiah, M | 1 |
| Sankham, MR | 1 |
| Kim, I | 1 |
| Lee, Y | 1 |
| Shin, I | 1 |
| Oh, AR | 1 |
| Lee, HJ | 1 |
| Vu, TNL | 1 |
| Park, J | 1 |
| Choi, S | 1 |
| Park, S | 1 |
| Kwon, Y | 1 |
| Fang, S | 1 |
| Kim, DK | 1 |
| Türker, F | 2 |
| Oral, A | 1 |
| Şahin, T | 1 |
| Türker, BÇ | 2 |
| Koçak, E | 1 |
| Ataoğlu, HE | 2 |
| Ahbab, S | 2 |
| Li, R | 1 |
| Zhou, L | 1 |
| Chen, C | 1 |
| Han, X | 1 |
| Gao, M | 1 |
| Cheng, X | 1 |
| Li, J | 1 |
| Liu, HX | 1 |
| Ren, YY | 1 |
| Meng, CQ | 1 |
| Li, Z | 2 |
| Nie, Q | 1 |
| Yu, CH | 1 |
| Ma, HJ | 1 |
| He, W | 3 |
| Huang, C | 3 |
| Wang, L | 3 |
| Su, W | 2 |
| Wang, S | 3 |
| Huang, P | 2 |
| Zhang, X | 6 |
| Huang, Y | 2 |
| Zhao, Y | 2 |
| Lin, M | 2 |
| Shi, X | 3 |
| Li, X | 3 |
| Fan, H | 1 |
| Li, L | 2 |
| Liu, Z | 1 |
| Cao, L | 1 |
| Chen, X | 2 |
| Suo, C | 1 |
| Zhang, T | 2 |
| Liu, Q | 1 |
| Li, H | 2 |
| Zhao, Q | 1 |
| Wang, Q | 1 |
| Zheng, Z | 1 |
| Wan, H | 1 |
| Yu, G | 1 |
| Xu, S | 1 |
| Jiang, Y | 1 |
| Duan, H | 1 |
| Lin, X | 1 |
| Ma, Q | 1 |
| Wang, D | 1 |
| Liang, Y | 1 |
| Liu, L | 3 |
| Shen, J | 1 |
| Marschner, RA | 1 |
| Roginski, AC | 1 |
| Ribeiro, RT | 1 |
| Longo, L | 1 |
| Álvares-da-Silva, MR | 1 |
| Wajner, SM | 1 |
| Zucchi, R | 1 |
| Huang, B | 1 |
| Yang, S | 1 |
| Ye, S | 1 |
| Zhang, J | 2 |
| Dai, Y | 1 |
| Qin, J | 1 |
| Shi, R | 1 |
| Lin, C | 1 |
| Hong, Y | 1 |
| Xia, X | 1 |
| Chen, Y | 1 |
| Li, S | 1 |
| Xiu, L | 1 |
| Gu, Y | 1 |
| Wu, X | 1 |
| Zhang, Q | 2 |
| Meng, G | 1 |
| Wu, H | 1 |
| Zhang, S | 1 |
| Wang, Y | 4 |
| Wang, X | 2 |
| Sun, S | 1 |
| Zhou, M | 1 |
| Jia, Q | 1 |
| Song, K | 1 |
| Niu, K | 1 |
| Quirós-González, V | 1 |
| Rubio, R | 1 |
| Pulido, F | 1 |
| Rial-Crestelo, D | 1 |
| Martín-Jurado, C | 1 |
| Hernández-Ros, MÁ | 1 |
| López-Jiménez, EA | 1 |
| Ferrari, JM | 1 |
| Caro-Teller, JM | 1 |
| Pinar, Ó | 1 |
| Pedrera-Jiménez, M | 1 |
| García-Barrio, N | 1 |
| Serrano, P | 1 |
| Bernal, JL | 1 |
| Tanguay, P | 1 |
| Décary, S | 1 |
| Martineau-Roy, J | 1 |
| Gravel, EM | 1 |
| Gervais, I | 1 |
| St-Jean, P | 1 |
| Tousignant, M | 1 |
| Marquis, N | 1 |
| Qian, L | 1 |
| Xuemei, L | 1 |
| Jitao, L | 1 |
| Yun'Ai, S | 1 |
| Tianmei, S | 1 |
| da Silva, HS | 1 |
| Nakamura, FY | 1 |
| Papoti, M | 1 |
| da Silva, AS | 1 |
| Dos-Santos, JW | 1 |
| Huth, SF | 1 |
| Cho, SM | 1 |
| Robba, C | 1 |
| Highton, D | 1 |
| Battaglini, D | 1 |
| Bellapart, J | 1 |
| Suen, JY | 1 |
| Li Bassi, G | 1 |
| Taccone, FS | 1 |
| Arora, RC | 1 |
| Whitman, G | 1 |
| Fraser, JF | 1 |
| Fanning, JP | 1 |
| Yang, B | 2 |
| Dmytriw, AA | 1 |
| Wang, T | 1 |
| Luo, J | 1 |
| Li, Y | 1 |
| Ma, Y | 1 |
| Chen, J | 1 |
| Gao, P | 1 |
| Feng, Y | 1 |
| Bai, X | 1 |
| Dong, J | 1 |
| Yang, R | 1 |
| Jiao, L | 2 |
| Ling, F | 1 |
| Ding, Y | 1 |
| Chen, Z | 1 |
| Pan, Y | 1 |
| Wang, J | 1 |
| Meng, X | 1 |
| Lin, J | 1 |
| Jing, J | 1 |
| Xie, X | 1 |
| Xiang, X | 1 |
| Lwi, SJ | 1 |
| Herron, TJ | 1 |
| Curran, BC | 1 |
| Ivanova, MV | 1 |
| Schendel, K | 1 |
| Dronkers, NF | 1 |
| Baldo, JV | 1 |
| Yi, X | 1 |
| Yang, Y | 1 |
| Zhao, Z | 2 |
| Xu, M | 1 |
| Zhang, Y | 4 |
| Sheng, Y | 1 |
| Tian, J | 1 |
| Xu, Z | 1 |
| Hua, W | 1 |
| Peng, Y | 1 |
| Han, Z | 1 |
| Li, T | 2 |
| Yin, C | 1 |
| Nan, G | 1 |
| Yang, H | 1 |
| Zhou, B | 1 |
| Cai, Y | 1 |
| Li, G | 1 |
| Peng, X | 1 |
| Guan, S | 1 |
| Zhou, J | 1 |
| Ye, M | 1 |
| Zhang, L | 1 |
| Hong, B | 1 |
| Wan, J | 1 |
| Zhu, Q | 1 |
| Liu, J | 1 |
| Yang, P | 1 |
| Guido, CA | 1 |
| Loffredo, L | 1 |
| Zicari, AM | 1 |
| Pavone, P | 1 |
| Savasta, S | 1 |
| Gagliano, A | 1 |
| Brindisi, G | 1 |
| Galardini, G | 1 |
| Bertolini, A | 1 |
| Spalice, A | 1 |
| Zheng, S | 1 |
| Wang, H | 2 |
| Chen, G | 1 |
| Shangguan, H | 1 |
| Yu, L | 1 |
| Lin, Z | 1 |
| Lin, Y | 1 |
| Yao, P | 1 |
| Kang, D | 1 |
| Guo, W | 1 |
| Qin, P | 1 |
| Li, XN | 1 |
| Wu, J | 2 |
| Lu, J | 1 |
| Zhu, WF | 1 |
| Diao, QQ | 1 |
| Xu, NZ | 1 |
| Valenzuela, R | 1 |
| Videla, LA | 1 |
| Liu, Y | 1 |
| Wang, W | 1 |
| Yu, X | 1 |
| Qi, X | 1 |
| Chen, P | 1 |
| Hou, X | 1 |
| Wei, L | 1 |
| Feng, L | 1 |
| Zhong, L | 1 |
| Bao, Y | 1 |
| Jia, W | 1 |
| Patel, VJ | 1 |
| Joharapurkar, AA | 1 |
| Kshirsagar, SG | 1 |
| Sutariya, BK | 1 |
| Patel, MS | 1 |
| Bahekar, RH | 1 |
| Jain, MR | 1 |
| Manka, P | 1 |
| Bechmann, L | 1 |
| Best, J | 1 |
| Sydor, S | 1 |
| Claridge, LC | 1 |
| Coombes, JD | 1 |
| Canbay, A | 1 |
| Moeller, L | 1 |
| Gerken, G | 1 |
| Wedemeyer, H | 1 |
| Syn, WK | 1 |
| Torun, E | 1 |
| Özgen, IT | 1 |
| Gökçe, S | 1 |
| Aydın, S | 1 |
| Cesur, Y | 1 |
| Bilgin, H | 1 |
| Pirgon, Ö | 1 |
| Tao, Y | 1 |
| Gu, H | 1 |
| Sui, J | 1 |
| Liu, G | 1 |
| Zheng, X | 1 |
| Guan, L | 1 |
| Jiang, Z | 1 |
| Lin, H | 1 |
| Jiang, Q | 1 |
| Zhang, N | 1 |
| Yu, C | 1 |
| Guan, Q | 1 |
| Ludwig, U | 1 |
| Holzner, D | 1 |
| Denzer, C | 1 |
| Greinert, A | 1 |
| Haenle, MM | 1 |
| Oeztuerk, S | 1 |
| Koenig, W | 1 |
| Boehm, BO | 1 |
| Mason, RA | 1 |
| Kratzer, W | 1 |
| Graeter, T | 1 |
| Gökmen, FY | 1 |
| Çetin, F | 1 |
| Mamaç, RY | 1 |
| Yenigün, M | 1 |
| Finan, B | 1 |
| Clemmensen, C | 1 |
| Zhu, Z | 1 |
| Stemmer, K | 1 |
| Gauthier, K | 1 |
| Müller, L | 1 |
| De Angelis, M | 1 |
| Moreth, K | 1 |
| Neff, F | 1 |
| Perez-Tilve, D | 1 |
| Fischer, K | 1 |
| Lutter, D | 1 |
| Sánchez-Garrido, MA | 1 |
| Liu, P | 1 |
| Tuckermann, J | 1 |
| Malehmir, M | 1 |
| Healy, ME | 1 |
| Weber, A | 1 |
| Heikenwalder, M | 1 |
| Jastroch, M | 1 |
| Kleinert, M | 1 |
| Jall, S | 1 |
| Brandt, S | 1 |
| Flamant, F | 1 |
| Schramm, KW | 1 |
| Biebermann, H | 1 |
| Döring, Y | 1 |
| Weber, C | 1 |
| Habegger, KM | 1 |
| Keuper, M | 1 |
| Gelfanov, V | 1 |
| Liu, F | 1 |
| Köhrle, J | 1 |
| Rozman, J | 1 |
| Fuchs, H | 1 |
| Gailus-Durner, V | 1 |
| Hrabě de Angelis, M | 1 |
| Hofmann, SM | 1 |
| Tschöp, MH | 1 |
| DiMarchi, R | 1 |
| Müller, TD | 1 |
| van den Berg, EH | 1 |
| van Tienhoven-Wind, LJ | 1 |
| Amini, M | 1 |
| Schreuder, TC | 1 |
| Faber, KN | 1 |
| Blokzijl, H | 1 |
| Dullaart, RP | 1 |
| Grasselli, E | 1 |
| Voci, A | 1 |
| Canesi, L | 1 |
| De Matteis, R | 1 |
| Goglia, F | 1 |
| Cioffi, F | 1 |
| Fugassa, E | 1 |
| Gallo, G | 1 |
| Vergani, L | 1 |
3 reviews available for triiodothyronine and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Thyroid Hormone Analogues: An Update.
Topics: Acetates; Anilides; Animals; Central Nervous System Diseases; Clinical Trials as Topic; Diiodothyron | 2020 |
Topics: Adult; China; Female; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver D | 2023 |
Crosstalk mechanisms in hepatoprotection: Thyroid hormone-docosahexaenoic acid (DHA) and DHA-extra virgin olive oil combined protocols.
Topics: Animals; Diet, High-Fat; Docosahexaenoic Acids; Drug Therapy, Combination; Humans; Liver; Non-alcoho | 2018 |
26 other studies available for triiodothyronine and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Discovery of (
Topics: Acrylates; Animals; Bile Acids and Salts; Esters; Intestines; Liver; Mice; Non-alcoholic Fatty Liver | 2022 |
Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis?
Topics: Alanine Transaminase; Aspartate Aminotransferases; Biopsy; Humans; Liver Cirrhosis; Non-alcoholic Fa | 2021 |
Sensitivity to thyroid hormones is associated with advanced fibrosis in euthyroid patients with non-alcoholic fatty liver disease: A cross-sectional study.
Topics: Cholesterol, LDL; Cross-Sectional Studies; Humans; Liver Cirrhosis; Non-alcoholic Fatty Liver Diseas | 2023 |
Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population.
Topics: Adiposity; Cross-Sectional Studies; Humans; Non-alcoholic Fatty Liver Disease; Risk Factors; Thyroxi | 2022 |
The correlation between triiodothyronine and the severity of liver fibrosis.
Topics: Animals; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Liver Cirrhosis; Membrane Glycoproteins | 2022 |
The correlation between triiodothyronine and the severity of liver fibrosis.
Topics: Animals; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Liver Cirrhosis; Membrane Glycoproteins | 2022 |
The correlation between triiodothyronine and the severity of liver fibrosis.
Topics: Animals; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Liver Cirrhosis; Membrane Glycoproteins | 2022 |
The correlation between triiodothyronine and the severity of liver fibrosis.
Topics: Animals; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Liver Cirrhosis; Membrane Glycoproteins | 2022 |
The association between thyroid hormones and MAFLD is mediated by obesity and metabolic disorders and varies among MAFLD subtypes.
Topics: Humans; Metabolic Diseases; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Thyroid Hormones | 2023 |
Role of aerobic exercise in ameliorating NASH: Insights into the hepatic thyroid hormone signaling and circulating thyroid hormones.
Topics: Animals; Inflammation; Liver Cirrhosis; Mice; Non-alcoholic Fatty Liver Disease; Physical Conditioni | 2022 |
Central Sensitivity to Free Triiodothyronine With MAFLD and Its Progression to Liver Fibrosis in Euthyroid Adults.
Topics: Adult; Humans; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Prospective Studies; Risk Factors | 2023 |
Uncovering Actions of Type 3 Deiodinase in the Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).
Topics: Animals; Iodide Peroxidase; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Thy | 2023 |
Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Humans; Insulin Resistance; Male; Middle Aged; Non-a | 2020 |
Serum Thyroid Hormones Levels are Significantly Associated with Nonalcoholic Fatty Liver Disease in Euthyroid Chinese Population.
Topics: China; Cross-Sectional Studies; Humans; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Ri | 2020 |
Free Triiodothyronine Is Independently Associated with Nonalcoholic Fatty Liver Disease in Hospitalized Type 2 Diabetes Mellitus Patients.
Topics: Adult; Aged; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Hospitalization; Hum | 2021 |
High-Normal Thyroid Function Predicts Incident Nonalcoholic Fatty Liver Disease Among Middle-Aged and Older Euthyroid Subjects.
Topics: Aged; Cohort Studies; Humans; Middle Aged; Non-alcoholic Fatty Liver Disease; Prospective Studies; T | 2022 |
Thyroid Function and Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects.
Topics: Adult; Age Factors; Biomarkers; China; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; N | 2018 |
Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women.
Topics: Alanine Transaminase; Cross-Sectional Studies; Disease Progression; Female; Humans; Liver Cirrhosis, | 2019 |
Activation of GLP-1 and Glucagon Receptors Regulates Bile Homeostasis Independent of Thyroid Hormone.
Topics: Animals; Bile; Diet, High-Fat; Glucagon-Like Peptide 1; Liver; Male; Methimazole; Mice; Mice, Inbred | 2019 |
Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis.
Topics: Biomarkers; Down-Regulation; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty | 2019 |
Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease.
Topics: Adolescent; Anthropometry; Biomarkers; Case-Control Studies; Child; Fatty Liver; Female; Follow-Up S | 2014 |
Thyroid function in obese children with non-alcoholic fatty liver disease.
Topics: Adolescent; Biomarkers; Blood Glucose; Case-Control Studies; Child; Female; Humans; Insulin; Insulin | 2014 |
Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects.
Topics: Adult; Cross-Sectional Studies; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Non-alcoholic | 2015 |
Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects.
Topics: Adult; China; Comorbidity; Female; Humans; Male; Menopause; Metabolic Syndrome; Middle Aged; Non-alc | 2015 |
Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years.
Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferases; Cross-Secti | 2015 |
FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism.
Topics: Adult; Biomarkers; Cholesterol; Female; Humans; Hypothyroidism; Insulin Resistance; Male; Metabolic | 2016 |
Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease.
Topics: Animals; Atherosclerosis; Body Weight; Bone and Bones; Chemical Engineering; Cholesterol; Diabetes M | 2016 |
Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Cross-Sectional Studies; Female; Humans; | 2017 |
Direct effects of iodothyronines on excess fat storage in rat hepatocytes.
Topics: Acyl-CoA Oxidase; Animals; Catalase; Cells, Cultured; Diiodothyronines; Fatty Liver; Gene Expression | 2011 |